Profilo
Steven Cha worked as Chief Medical Officer at Imugene Ltd. in 2022.
Dr. Cha worked as Chief Medical Officer at NKGen Operating Biotech, Inc. Dr. Cha worked as Senior Vice President-Clinical Research at Processa Pharmaceuticals, Inc. Dr. Cha completed undergraduate studies at the University of California San Diego and earned a doctorate from Tufts University School of Medicine.
Precedenti posizioni note di Steven Cha
| Società | Posizione | Fine |
|---|---|---|
| IMUGENE LIMITED | Direttore Tecnico/Scientifico/R&S | 01/06/2022 |
| PROCESSA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Steven Cha
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Health Technology |
















